Professor David Ridley will share insights from his new research that suggests that the way Medicare pays health care providers for drugs inadvertently encourages drug makers to charge higher prices.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Rep. Frank Pallone Jr. speaks at a Capitol Hill press conference Sept. 19, 2019, announcing legislation to allow the government to negotiate with drug companies for lower prices.
Duke Fuqua Insights
What are these vouchers, why is the FDA issuing them and what benefit might they have for society?